While we did not perform repeat biopsies after cryotherapy to evaluate this possibility, a recent study of eight metastatic NSCLC patients by Desilets et al. found significant upregulation of tumor-infiltrating CD8 T cells in cases where a clinical benefit from immunotherapy with pembrolizumab was observed [27]. This evidence concerns the gene CD8A and non-small cell lung carcinoma.